Zheng, Ruifang <br/><br/>
Optimal AraC-Cytotoxicity to AML Cells Requires ERK5 Activity.  [electronic resource] 

 -  Journal of cellular biochemistry  06 2017 
 - 1583-1589 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-4644 
<br/><br/><label>Standard No.: </label>10.1002/jcb.25820  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aniline Compounds--pharmacology<br/>Antimetabolites, Antineoplastic--pharmacology<br/>Benzodiazepinones--pharmacology<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cytarabine--pharmacology<br/>Gene Expression Regulation, Leukemic--drug effects<br/>HL-60 Cells<br/>Humans<br/>Indoles--pharmacology<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Mitogen-Activated Protein Kinase 7--antagonists & inhibitors<br/>Phosphorylation--drug effects<br/>Proto-Oncogene Proteins c-bcl-2--metabolism